Skip to content. | Skip to navigation

Personal tools

This is SunRain Plone Theme

Navigation

banner13
banner0
banner11
banner1
banner6
banner7
banner10
banner12
banner17
banner16
banner5
banner3
banner4
banner14
banner9
banner18
banner2
banner8
banner15
You are here: Home / Staff / Agreements with industrial partners

Agreements with industrial partners

 The IGB-ABT strongly believes that a close collaboration between academia and the industrial sector represents a key element to carry out innovative research. Indeed, several groups closely interact with SMEs and big pharmaceutical companies: GW Pharmaceuticals, Genzyme-Sanofi, Sigma-Tau, Bio-Ker, Multimedica Group, Diatech Pharmacogenetics and Selyno. The ultimate goal is to either 1) develop novel drugs, 2) identify novel biomarkers, or 3) better characterize human rare diseases. In addition, IGB-ABT has 3 active patents and 3 novel patent applications.

  Bioker s.r.l. phone/fax: +39 081 6132 412

  • Giancarlo Tonon
  • Silvia Scaramuzza
  • Rodolfo Schrepfer
  • Fabio Selis

 

IRBM  phone/fax: +39 081 6132 463

  • Francesca Varrone
  • Giacomo Metta
  • Luca Giorgio Wanderlingh